Contact Us
Home 8-K/A

SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
Jul 19, 2021
Document Date
May 5, 2021
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC